Average Co-Inventor Count = 6.72
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (17 from 3,923 patents)
17 patents:
1. 12441733 - Substituted 2,4-dioxotetrahydropyrimidines as intermediates in the synthesis of bruton's tyrosine kinase inhibitors
2. 11878973 - Bicyclic compounds and their uses
3. 11613543 - Substituted pyrrolo[2,3-d]pyrimidines as Bruton's Tyrosine Kinase inhibitors
4. 11541056 - 3-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carboxamide derivatives
5. 9556180 - Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the P53/MDM2 interaction
6. 9403827 - Substituted purinone compounds
7. 9365576 - Pyrrolopyrrolidinone compounds
8. 9051279 - Substituted isoquinolinones and quinazolinones
9. 8969341 - Pyrazolopyrrolidine compounds
10. 8859586 - Cyclohexyl isoquinolinone compounds
11. 8859535 - Hydroxy substituted isoquinolinone derivatives
12. 8815926 - Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseases
13. 8440693 - Substituted isoquinolinones and quinazolinones
14. 8420657 - Pyrrolo[2,3-D]pyrimidines and use thereof as tyrosine kinase inhibitors
15. 8207164 - Oxazine derivatives and their use in the treatment of neurological disorders